脱细胞人真皮支架与牛胶原/弹性蛋白基质用于软组织皮瓣工程的比较
在大鼠动静脉环(AVL)模型中比较脱细胞人真皮支架(Epiflex)与牛胶原/弹性蛋白基质(MatriDerm)构建软组织皮瓣的效果。术后28天两组微血管网络、微血管计数、表面积及增殖细胞比例无差异,但人支架组体积保持与组织稳定性显著优于牛基质组。
要点
- 人脱细胞真皮支架组术后21天体积保持102%±5%,牛基质组27%±7%。
- 术后28天体积保持人支架组79%±12%,牛基质组12%±7%(P<0.0001)。
- 两组微血管计数、表面积及增殖细胞比例无显著差异。
核心结论
- 与牛基质相比,脱细胞人支架在大鼠AVL皮瓣中实现更优的体积保持和组织稳定性。
研究设计与样本
- 在28只免疫健全大鼠中构建AVL,实验组n=14植入脱细胞人真皮支架(Epiflex),对照组n=14植入牛胶原/弹性蛋白基质(MatriDerm),置于皮下聚四氟乙烯腔室。
主要发现
- 术后28天两组组织病理与微型CT均显示均匀微血管网络。
- 两组平均微血管计数、表面积及增殖细胞百分比无差异。
- 实验组体积丢失显著小于对照组:术后21天体积保持102%±5% vs 27%±7%,术后28天79%±12% vs 12%±7%(P<0.0001)。
- 实验组组织降解显著少于对照组。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Free flap-based soft-tissue reconstruction comes at the price of donor-site morbidity. The arteriovenous loop (AVL) technique can overcome this issue by allowing for the de novo generation of axially vascularized soft-tissue flaps from vein grafts embedded into different matrices. Application of the AVL technique has been limited by insufficient long-term volume retention and poor tissue stability. The authors investigated the suitability of a novel human dermal scaffold to improve volume retention and tissue stability. METHODS: AVLs were created in 28 immunocompetent rats and embedded in either decellularized human dermal scaffolds (experimental group, n = 14) (Epiflex) or bovine collagen/elastin matrices (control group, n = 14) (MatriDerm) in subcutaneous polytetrafluoroethylene chambers. The weight and volume of engineered tissues, the extent of angiogenesis, and the proportion of proliferating cells were compared between groups on postoperative days (PODs) 21 and 28 by means of immunohistochemistry and micro-computed tomography. RESULTS: On POD 28, both groups displayed homogeneous microvascular networks on histopathology and micro-computed tomography. Mean microvessel counts and surface areas and the percentage of proliferating cells did not differ between the groups. However, the experimental human scaffold group displayed significantly smaller volume loss and significantly less tissue degradation compared with bovine matrix controls (volume retention, 102% ± 5% versus 27% ± 7% on POD 21, and 79% ± 12% versus 12% ± 7% on POD 28, respectively; P < 0.0001). CONCLUSION: Compared with bovine matrices, decellularized human scaffolds allow for superior volume retention and tissue stability of de novo engineered soft-tissue AVL flaps in rats. CLINICAL RELEVANCE STATEMENT: AVLs allow for the de novo generation of vascularized soft-tissue flaps. However, insufficient long-term volume retention is still an issue. The authors' study shows that decellularized human matrices guarantee superior volume stability of de novo grown soft-tissue flaps in rats.
引用
- Falkner F, Mayer SA, Heuer M, et al. Comparison of Decellularized Human Dermal Scaffolds versus Bovine Collagen/Elastin Matrices for Engineering of Soft-Tissue Flaps. Plast Reconstr Surg. 2023. PMID: 37014963. doi:10.1097/PRS.0000000000010511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。